Abera Bioscience AB (FRA:8WK)
Germany · Delayed Price · Currency is EUR 0.5700
+0.0200 (3.64%)
At close: Dec 19, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of €11.2 million as of December 22, 2025. Its market cap has increased by 115.51% in one year.
Market Cap
11.20M
Enterprise Value
9.07M
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.57
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 11.47M to 11.20M, a decrease of -2.33%. That is a compound annual growth rate of -0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 11.20M | 85.40% |
| Dec 30, 2024 | 6.04M | -9.75% |
| Dec 29, 2023 | 6.69M | 20.37% |
| Dec 30, 2022 | 5.56M | -67.10% |
| Dec 30, 2021 | 16.90M | 47.38% |
| Feb 24, 2021 | 11.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |